Bannari Amman Sugars Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: April 24, 2025, 9:56 pm

Market Cap	5,270 Cr.
Current Price	4,136
High / Low	4,495/2,189
Stock P/E	57.7
Book Value	1,380
Dividend Yield	0.30 %
ROCE	11.8 %
ROE	9.36 %
Face Value	10.0
PEG Ratio	-335.34

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Bannari Amman Sugars Ltd

Competitors of Bannari Amman Sugars Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Gayatri Sugars Ltd	69.6 Cr.	9.36	26.5/8.06		19.1	0.00 %	93.2 %	%	10.0
Dhampure Speciality Sugars Ltd	89.7 Cr.	108	142/78.0	54.1	35.6	0.00 %	3.15 %	3.78 %	10.0
Dhampur Bio Organics Ltd	489 Cr.	74.5	164/57.3	44.2	146	3.36 %	5.02 %	3.67 %	10.0
DCM Shriram Industries Ltd	1,593 Cr.	183	242/142	13.7	100	1.09 %	16.1 %	14.9 %	2.00
Davangere Sugar Company Ltd	367 Cr.	3.91	10.9/3.45	27.1	3.64	0.00 %	6.86 %	3.75 %	1.00
Industry Average	2,101.81 Cr	312.71		23.55	224.49	0.74%	13.00%	13.21%	6.37

All Competitor Stocks of Bannari Amman Sugars Ltd

Quarterly Result

Metric	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	716	462	427	510	932	656	431	600	768	421	404	474	421
Expenses	650	392	392	442	835	553	387	508	649	370	375	406	360
Operating Profit	65	70	35	68	98	103	44	92	119	51	29	67	61
OPM %	9%	15%	8%	13%	10%	16%	10%	15%	16%	12%	7%	14%	15%
Other Income	1	2	34	2	2	2	1	2	2	2	1	2	1
Interest	8	9	13	13	13	10	10	7	7	8	6	2	4
Depreciation	15	22	18	19	19	18	14	14	14	15	14	14	14
Profit before tax	44	41	38	38	68	76	20	73	100	31	10	53	45
Tax %	33%	41%	33%	29%	40%	35%	33%	33%	32%	30%	35%	35%	35%
Net Profit	30	24	26	27	41	50	14	49	68	22	6	34	29
EPS in Rs	23.56	19.36	20.49	21.48	32.58	39.81	10.84	38.92	54.28	17.41	5.13	27.33	22.98

Last Updated: March 3, 2025, 5:20 pm

Below is a detailed analysis of the quarterly data for Bannari Amman Sugars Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Sales, as of Dec 2024, the value is 421.00 Cr.. The value appears to be declining and may need further review. It has decreased from 474.00 Cr. (Sep 2024) to 421.00 Cr., marking a decrease of 53.00 Cr..
For Expenses, as of Dec 2024, the value is 360.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 406.00 Cr. (Sep 2024) to 360.00 Cr., marking a decrease of 46.00 Cr..
For Operating Profit, as of Dec 2024, the value is 61.00 Cr.. The value appears to be declining and may need further review. It has decreased from 67.00 Cr. (Sep 2024) to 61.00 Cr., marking a decrease of 6.00 Cr..
For OPM %, as of Dec 2024, the value is 15.00%. The value appears strong and on an upward trend. It has increased from 14.00% (Sep 2024) to 15.00%, marking an increase of 1.00%.
For Other Income, as of Dec 2024, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2.00 Cr. (Sep 2024) to 1.00 Cr., marking a decrease of 1.00 Cr..
For Interest, as of Dec 2024, the value is 4.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.00 Cr. (Sep 2024) to 4.00 Cr., marking an increase of 2.00 Cr..
For Depreciation, as of Dec 2024, the value is 14.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 14.00 Cr..
For Profit before tax, as of Dec 2024, the value is 45.00 Cr.. The value appears to be declining and may need further review. It has decreased from 53.00 Cr. (Sep 2024) to 45.00 Cr., marking a decrease of 8.00 Cr..
For Tax %, as of Dec 2024, the value is 35.00%. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 35.00%.
For Net Profit, as of Dec 2024, the value is 29.00 Cr.. The value appears to be declining and may need further review. It has decreased from 34.00 Cr. (Sep 2024) to 29.00 Cr., marking a decrease of 5.00 Cr..
For EPS in Rs, as of Dec 2024, the value is 22.98. The value appears to be declining and may need further review. It has decreased from 27.33 (Sep 2024) to 22.98, marking a decrease of 4.35.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 7, 2025, 9:06 pm

Metric	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	1,337	651	930	1,456	1,752	1,481	1,125	1,609	1,563	1,998	2,526	2,220	1,720
Expenses	1,052	503	802	1,251	1,404	1,270	943	1,378	1,352	1,780	2,221	1,914	1,511
Operating Profit	285	148	128	204	348	211	182	231	211	218	304	306	209
OPM %	21%	23%	14%	14%	20%	14%	16%	14%	13%	11%	12%	14%	12%
Other Income	-6	-2	16	3	6	5	8	4	9	3	39	7	7
Interest	45	62	93	116	97	34	30	44	39	32	49	32	20
Depreciation	60	52	51	62	69	70	67	65	66	68	74	58	57
Profit before tax	174	32	0	30	187	112	93	126	115	122	220	224	139
Tax %	18%	11%	-209%	-7%	22%	22%	18%	24%	20%	34%	35%	32%
Net Profit	142	29	1	32	145	87	76	96	92	80	143	152	91
EPS in Rs	124.56	25.08	0.90	27.73	115.77	69.59	60.56	76.27	73.48	63.78	114.35	121.45	72.85
Dividend Payout %	10%	50%	278%	27%	11%	14%	17%	13%	14%	16%	11%	10%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2013-2014	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	-79.58%	-96.55%	3100.00%	353.12%	-40.00%	-12.64%	26.32%	-4.17%	-13.04%	78.75%	6.29%
Change in YoY Net Profit Growth (%)	0.00%	-16.97%	3196.55%	-2746.88%	-393.12%	27.36%	38.96%	-30.48%	-8.88%	91.79%	-72.46%

Bannari Amman Sugars Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	13%
5 Years:	15%
3 Years:	12%
TTM:	-30%

Compounded Profit Growth
10 Years:	17%
5 Years:	15%
3 Years:	19%
TTM:	-49%

Stock Price CAGR
10 Years:	17%
5 Years:	36%
3 Years:	15%
1 Year:	56%

Return on Equity
10 Years:	7%
5 Years:	8%
3 Years:	8%
Last Year:	9%

Last Updated: Unknown

Balance Sheet

Last Updated: December 14, 2024, 3:55 pm

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	11	11	11	11	13	13	13	13	13	13	13	13	13
Reserves	931	943	940	920	1,055	1,123	1,183	1,262	1,344	1,411	1,539	1,676	1,718
Borrowings	458	1,052	1,221	1,534	1,038	508	769	996	872	961	581	486	162
Other Liabilities	315	274	232	355	297	143	237	164	163	184	226	260	316
Total Liabilities	1,715	2,281	2,405	2,821	2,402	1,786	2,202	2,434	2,390	2,569	2,359	2,435	2,209
Fixed Assets	669	632	917	1,138	1,103	1,082	1,026	1,004	954	1,049	1,078	1,071	1,060
CWIP	33	268	22	15	34	4	24	90	145	61	22	112	144
Investments	0	0	0	1	2	1	1	1	1	1	2	3	5
Other Assets	1,013	1,381	1,466	1,667	1,263	699	1,151	1,340	1,291	1,458	1,257	1,249	1,000
Total Assets	1,715	2,281	2,405	2,821	2,402	1,786	2,202	2,434	2,390	2,569	2,359	2,435	2,209

Below is a detailed analysis of the balance sheet data for Bannari Amman Sugars Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is ₹13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 13.00 Cr..
For Reserves, as of Sep 2024, the value is ₹1,718.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,676.00 Cr. (Mar 2024) to ₹1,718.00 Cr., marking an increase of 42.00 Cr..
For Borrowings, as of Sep 2024, the value is ₹162.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 486.00 Cr. (Mar 2024) to ₹162.00 Cr., marking a decrease of 324.00 Cr..
For Other Liabilities, as of Sep 2024, the value is ₹316.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 260.00 Cr. (Mar 2024) to ₹316.00 Cr., marking an increase of 56.00 Cr..
For Total Liabilities, as of Sep 2024, the value is ₹2,209.00 Cr.. The value appears to be improving (decreasing). It has decreased from 2,435.00 Cr. (Mar 2024) to ₹2,209.00 Cr., marking a decrease of 226.00 Cr..
For Fixed Assets, as of Sep 2024, the value is ₹1,060.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,071.00 Cr. (Mar 2024) to ₹1,060.00 Cr., marking a decrease of 11.00 Cr..
For CWIP, as of Sep 2024, the value is ₹144.00 Cr.. The value appears strong and on an upward trend. It has increased from 112.00 Cr. (Mar 2024) to ₹144.00 Cr., marking an increase of 32.00 Cr..
For Investments, as of Sep 2024, the value is ₹5.00 Cr.. The value appears strong and on an upward trend. It has increased from 3.00 Cr. (Mar 2024) to ₹5.00 Cr., marking an increase of 2.00 Cr..
For Other Assets, as of Sep 2024, the value is ₹1,000.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,249.00 Cr. (Mar 2024) to ₹1,000.00 Cr., marking a decrease of 249.00 Cr..
For Total Assets, as of Sep 2024, the value is ₹2,209.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,435.00 Cr. (Mar 2024) to ₹2,209.00 Cr., marking a decrease of 226.00 Cr..

Notably, the Reserves (1,718.00 Cr.) exceed the Borrowings (162.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	158	-255	20	178	645	588	-192	-57	236	33	502	274
Cash from Investing Activity +	-57	-253	-74	-275	-52	-16	-27	-106	-61	-75	-57	-130
Cash from Financing Activity +	-103	509	61	107	-604	-579	219	167	-179	42	-443	-144
Net Cash Flow	-1	0	7	10	-11	-6	0	4	-5	-0	3	1

Free Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	-173.00	147.00	127.00	203.00	347.00	-297.00	-587.00	-765.00	-661.00	-743.00	-277.00	-180.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	27	23	16	33	24	17	42	43	38	63	20	22
Inventory Days	348	1,542	757	485	296	188	529	330	339	255	205	247
Days Payable	60	97	39	50	27	28	95	21	20	22	17	19
Cash Conversion Cycle	315	1,468	734	468	293	176	476	352	356	296	209	249
Working Capital Days	178	602	465	278	164	114	274	255	260	234	146	170
ROCE %	17%	6%	4%	6%	12%	8%	7%	8%	7%	7%	12%	12%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	58.70%	58.70%	58.69%	58.69%	58.69%	58.69%	58.69%	58.69%	58.69%	58.69%	58.69%	58.69%
FIIs	0.23%	0.26%	0.27%	0.26%	0.26%	0.26%	0.26%	0.26%	0.25%	0.25%	0.27%	0.27%
DIIs	0.06%	0.00%	0.00%	0.00%	0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	41.01%	41.04%	41.04%	41.05%	41.04%	41.04%	41.03%	41.04%	41.04%	41.05%	41.04%	41.03%
No. of Shareholders	8,643	8,618	8,290	8,177	7,895	7,861	8,462	8,766	8,694	8,662	8,718	8,297

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	121.46	114.35	63.78	73.48	76.27
Diluted EPS (Rs.)	121.46	114.35	63.78	73.48	76.27
Cash EPS (Rs.)	167.38	173.39	117.90	125.89	128.05
Book Value[Excl.RevalReserv]/Share (Rs.)	1346.44	1237.58	1135.11	1081.43	1016.72
Book Value[Incl.RevalReserv]/Share (Rs.)	1346.44	1237.58	1135.11	1081.43	1016.72
Dividend / Share (Rs.)	12.50	12.50	10.00	10.00	10.00
Revenue From Operations / Share (Rs.)	1770.63	2014.06	1593.41	1244.99	1283.36
PBDIT / Share (Rs.)	249.69	273.99	176.24	175.12	187.66
PBIT / Share (Rs.)	203.76	214.95	122.13	122.71	135.87
PBT / Share (Rs.)	178.52	175.61	97.08	91.34	100.52
Net Profit / Share (Rs.)	121.46	114.35	63.78	73.48	76.27
PBDIT Margin (%)	14.10	13.60	11.06	14.06	14.62
PBIT Margin (%)	11.50	10.67	7.66	9.85	10.58
PBT Margin (%)	10.08	8.71	6.09	7.33	7.83
Net Profit Margin (%)	6.85	5.67	4.00	5.90	5.94
Return on Networth / Equity (%)	9.02	9.23	5.61	6.79	7.50
Return on Capital Employeed (%)	13.71	15.09	9.63	9.94	11.04
Return On Assets (%)	6.25	6.07	3.11	3.85	3.92
Long Term Debt / Equity (X)	0.03	0.10	0.08	0.12	0.19
Total Debt / Equity (X)	0.28	0.37	0.67	0.62	0.76
Asset Turnover Ratio (%)	0.92	1.03	0.80	0.64	0.69
Current Ratio (X)	2.09	2.04	1.46	1.49	1.46
Quick Ratio (X)	0.32	0.33	0.43	0.31	0.38
Inventory Turnover Ratio (X)	1.55	1.72	1.46	1.14	1.16
Dividend Payout Ratio (NP) (%)	10.29	8.74	15.67	13.60	13.11
Dividend Payout Ratio (CP) (%)	7.46	5.76	8.48	7.94	7.80
Earning Retention Ratio (%)	89.71	91.26	84.33	86.40	86.89
Cash Earning Retention Ratio (%)	92.54	94.24	91.52	92.06	92.20
Interest Coverage Ratio (X)	9.89	6.97	7.03	5.58	5.31
Interest Coverage Ratio (Post Tax) (X)	5.81	3.91	3.55	3.34	3.16
Enterprise Value (Cr.)	3372.02	3986.56	4309.94	2808.96	2070.43
EV / Net Operating Revenue (X)	1.52	1.58	2.16	1.80	1.29
EV / EBITDA (X)	10.77	11.60	19.50	12.79	8.80
MarketCap / Net Operating Revenue (X)	1.30	1.35	1.68	1.26	0.68
Retention Ratios (%)	89.70	91.25	84.32	86.39	86.88
Price / BV (X)	1.71	2.20	2.36	1.45	0.86
Price / Net Operating Revenue (X)	1.30	1.35	1.68	1.26	0.68
EarningsYield	0.05	0.04	0.02	0.04	0.08

After reviewing the key financial ratios for Bannari Amman Sugars Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 24, the value is 121.46. This value is within the healthy range. It has increased from 114.35 (Mar 23) to 121.46, marking an increase of 7.11.
For Diluted EPS (Rs.), as of Mar 24, the value is 121.46. This value is within the healthy range. It has increased from 114.35 (Mar 23) to 121.46, marking an increase of 7.11.
For Cash EPS (Rs.), as of Mar 24, the value is 167.38. This value is within the healthy range. It has decreased from 173.39 (Mar 23) to 167.38, marking a decrease of 6.01.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 1,346.44. It has increased from 1,237.58 (Mar 23) to 1,346.44, marking an increase of 108.86.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 1,346.44. It has increased from 1,237.58 (Mar 23) to 1,346.44, marking an increase of 108.86.
For Dividend / Share (Rs.), as of Mar 24, the value is 12.50. This value exceeds the healthy maximum of 3. There is no change compared to the previous period (Mar 23) which recorded 12.50.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 1,770.63. It has decreased from 2,014.06 (Mar 23) to 1,770.63, marking a decrease of 243.43.
For PBDIT / Share (Rs.), as of Mar 24, the value is 249.69. This value is within the healthy range. It has decreased from 273.99 (Mar 23) to 249.69, marking a decrease of 24.30.
For PBIT / Share (Rs.), as of Mar 24, the value is 203.76. This value is within the healthy range. It has decreased from 214.95 (Mar 23) to 203.76, marking a decrease of 11.19.
For PBT / Share (Rs.), as of Mar 24, the value is 178.52. This value is within the healthy range. It has increased from 175.61 (Mar 23) to 178.52, marking an increase of 2.91.
For Net Profit / Share (Rs.), as of Mar 24, the value is 121.46. This value is within the healthy range. It has increased from 114.35 (Mar 23) to 121.46, marking an increase of 7.11.
For PBDIT Margin (%), as of Mar 24, the value is 14.10. This value is within the healthy range. It has increased from 13.60 (Mar 23) to 14.10, marking an increase of 0.50.
For PBIT Margin (%), as of Mar 24, the value is 11.50. This value is within the healthy range. It has increased from 10.67 (Mar 23) to 11.50, marking an increase of 0.83.
For PBT Margin (%), as of Mar 24, the value is 10.08. This value is within the healthy range. It has increased from 8.71 (Mar 23) to 10.08, marking an increase of 1.37.
For Net Profit Margin (%), as of Mar 24, the value is 6.85. This value is within the healthy range. It has increased from 5.67 (Mar 23) to 6.85, marking an increase of 1.18.
For Return on Networth / Equity (%), as of Mar 24, the value is 9.02. This value is below the healthy minimum of 15. It has decreased from 9.23 (Mar 23) to 9.02, marking a decrease of 0.21.
For Return on Capital Employeed (%), as of Mar 24, the value is 13.71. This value is within the healthy range. It has decreased from 15.09 (Mar 23) to 13.71, marking a decrease of 1.38.
For Return On Assets (%), as of Mar 24, the value is 6.25. This value is within the healthy range. It has increased from 6.07 (Mar 23) to 6.25, marking an increase of 0.18.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.03. This value is below the healthy minimum of 0.2. It has decreased from 0.10 (Mar 23) to 0.03, marking a decrease of 0.07.
For Total Debt / Equity (X), as of Mar 24, the value is 0.28. This value is within the healthy range. It has decreased from 0.37 (Mar 23) to 0.28, marking a decrease of 0.09.
For Asset Turnover Ratio (%), as of Mar 24, the value is 0.92. It has decreased from 1.03 (Mar 23) to 0.92, marking a decrease of 0.11.
For Current Ratio (X), as of Mar 24, the value is 2.09. This value is within the healthy range. It has increased from 2.04 (Mar 23) to 2.09, marking an increase of 0.05.
For Quick Ratio (X), as of Mar 24, the value is 0.32. This value is below the healthy minimum of 1. It has decreased from 0.33 (Mar 23) to 0.32, marking a decrease of 0.01.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.55. This value is below the healthy minimum of 4. It has decreased from 1.72 (Mar 23) to 1.55, marking a decrease of 0.17.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 10.29. This value is below the healthy minimum of 20. It has increased from 8.74 (Mar 23) to 10.29, marking an increase of 1.55.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 7.46. This value is below the healthy minimum of 20. It has increased from 5.76 (Mar 23) to 7.46, marking an increase of 1.70.
For Earning Retention Ratio (%), as of Mar 24, the value is 89.71. This value exceeds the healthy maximum of 70. It has decreased from 91.26 (Mar 23) to 89.71, marking a decrease of 1.55.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 92.54. This value exceeds the healthy maximum of 70. It has decreased from 94.24 (Mar 23) to 92.54, marking a decrease of 1.70.
For Interest Coverage Ratio (X), as of Mar 24, the value is 9.89. This value is within the healthy range. It has increased from 6.97 (Mar 23) to 9.89, marking an increase of 2.92.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 5.81. This value is within the healthy range. It has increased from 3.91 (Mar 23) to 5.81, marking an increase of 1.90.
For Enterprise Value (Cr.), as of Mar 24, the value is 3,372.02. It has decreased from 3,986.56 (Mar 23) to 3,372.02, marking a decrease of 614.54.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.52. This value is within the healthy range. It has decreased from 1.58 (Mar 23) to 1.52, marking a decrease of 0.06.
For EV / EBITDA (X), as of Mar 24, the value is 10.77. This value is within the healthy range. It has decreased from 11.60 (Mar 23) to 10.77, marking a decrease of 0.83.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.30. This value is within the healthy range. It has decreased from 1.35 (Mar 23) to 1.30, marking a decrease of 0.05.
For Retention Ratios (%), as of Mar 24, the value is 89.70. This value exceeds the healthy maximum of 70. It has decreased from 91.25 (Mar 23) to 89.70, marking a decrease of 1.55.
For Price / BV (X), as of Mar 24, the value is 1.71. This value is within the healthy range. It has decreased from 2.20 (Mar 23) to 1.71, marking a decrease of 0.49.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.30. This value is within the healthy range. It has decreased from 1.35 (Mar 23) to 1.30, marking a decrease of 0.05.
For EarningsYield, as of Mar 24, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 23) to 0.05, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Bannari Amman Sugars Ltd as of April 25, 2025 is: 5,980.28

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of April 25, 2025, Bannari Amman Sugars Ltd is Undervalued by 44.59% compared to the current share price 4,136.00

Intrinsic Value of Bannari Amman Sugars Ltd as of April 25, 2025 is: 5,969.99

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of April 25, 2025, Bannari Amman Sugars Ltd is Undervalued by 44.34% compared to the current share price 4,136.00

Last 5 Year EPS CAGR: -0.17%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The company has higher reserves (1,234.23 cr) compared to borrowings (818.31 cr), indicating strong financial stability. The company has shown consistent growth in sales (122.62 cr) and profit (121.08 cr) over the years.	The stock has a low average ROCE of 8.83%, which may not be favorable. The stock has a high average Working Capital Days of 261.67, which may not be favorable. The stock has a high average Cash Conversion Cycle of 327.08, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Bannari Amman Sugars Ltd:
1. Net Profit Margin: 6.85%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 13.71% (Industry Average ROCE: 13%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 9.02% (Industry Average ROE: 11.89%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 5.81
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 0.32
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 57.7 (Industry average Stock P/E: 17.27)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.28
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Bannari Amman Sugars Ltd. is a Public Limited Listed company incorporated on 01/12/1983 and has its registered office in the State of Tamil Nadu, India. Company's Corporate Identification Number(CIN) is L15421TZ1983PLC001358 and registration number is 001358. Currently Company is involved in the business activities of Manufacture or refining of sugar (sucrose) from sugercane. Company's Total Operating Revenue is Rs. 2220.32 Cr. and Equity Capital is Rs. 12.54 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
Sugar	1212, Trichy Road, Coimbatore Tamil Nadu 641018	shares@bannari.com http://www.bannari.com

Management
Name	Position Held
Mr. S V Balasubramaniam	Chairman
Mr. B Saravanan	Managing Director
Dr. M P Vijayakumar	Ind. Non-Executive Director
Mr. A K Perumalsamy	Ind. Non-Executive Director
Mr. T Gundan	Ind. Non-Executive Director
Dr. Radha Ramani	Ind. Non-Executive Woman Director

FAQ

What is the intrinsic value of Bannari Amman Sugars Ltd?

Bannari Amman Sugars Ltd's intrinsic value (as of 25 April 2025) is ₹5980.28 — 44.59% higher the current market price of 4,136.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 5,270 Cr. market cap, FY2025-2026 high/low of ₹4,495/2,189, reserves of 1,718 Cr, and liabilities of 2,209 Cr.

What is the Market Cap of Bannari Amman Sugars Ltd?

The Market Cap of Bannari Amman Sugars Ltd is 5,270 Cr..

What is the current Stock Price of Bannari Amman Sugars Ltd as on 25 April 2025?

The current stock price of Bannari Amman Sugars Ltd as on 25 April 2025 is 4,136.

What is the High / Low of Bannari Amman Sugars Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Bannari Amman Sugars Ltd stocks is ₹4,495/2,189.

What is the Stock P/E of Bannari Amman Sugars Ltd?

The Stock P/E of Bannari Amman Sugars Ltd is 57.7.

What is the Book Value of Bannari Amman Sugars Ltd?

The Book Value of Bannari Amman Sugars Ltd is 1,380.

What is the Dividend Yield of Bannari Amman Sugars Ltd?

The Dividend Yield of Bannari Amman Sugars Ltd is 0.30 %.

What is the ROCE of Bannari Amman Sugars Ltd?

The ROCE of Bannari Amman Sugars Ltd is 11.8 %.

What is the ROE of Bannari Amman Sugars Ltd?

The ROE of Bannari Amman Sugars Ltd is 9.36 %.

What is the Face Value of Bannari Amman Sugars Ltd?

The Face Value of Bannari Amman Sugars Ltd is 10.0.